Lavanya Malhotra: The ice bucket challenge—trivialising trend or canny awareness campaign?

Lately, social media sites have been invaded by videos of people upending buckets of icy water over their heads. The goal behind this watery exercise is to raise funds, as well as awareness, for amyotrophic lateral sclerosis (ALS) research. The ALS ice bucket challenge is simple: douse yourself in icy water, record it, post it online—on […]

Read More…

Paul Teed: Is medical opinion shifting towards support for an assisted dying law?

Over the weekend, the Times published findings from a new survey conducted by Medix, which asked 600 doctors various questions on assisted dying, assisted suicide, and euthanasia. The coverage contrasted the findings with those from a similar Medix survey a decade ago, reported then in The BMJ. But reading the complete data in the new survey […]

Read More…

The BMJ Today: If wishes were sustainable development goals

Fourteen years ago, leaders from across the world came together at the United Nations headquarters in New York to pledge their efforts towards achieving eight targets for global development. Together, these targets became known as the millennium development goals or MDGs (with three of them directly devoted to a health objective). Since then, The BMJ, […]

Read More…

Jasmin Islam: Ebola readiness—lessons from a district general hospital

Since the Ebola outbreak was confirmed back in March 2014, I, like many doctors, have been following its progress with a great deal of interest and sadness over the increasing number of deaths, which have included several healthcare workers. In relation to the current outbreak, there have been no confirmed cases of Ebola in the […]

Read More…

David Zigmond: Can we always “treat” our tragic paradoxes?

Robin Williams’s recent death is a familiar shock: another premature loss of a publicly loved figure. How do we understand and respond to such tragic discrepancy? On the radio (BBC’s Today programme on Radio 4, 15/8/2014) there were lengthy interviews with two publicly accountable experts: the director of long term conditions for NHS England and the president of […]

Read More…

The BMJ Today: Medicine’s vast horizons

At first glance, three articles published this week in The BMJ appear to have limited relevance to medicine. One, written by an economist, discusses the challenges faced by demographers when making predictions about population changes; a second deals with international drug control treaties and the need for policy experiments to evaluate the benefits and risks […]

Read More…

James Raftery: Sofosbuvir for hepatitis C—moving to country specific prices

The National Institute for Health and Care Excellence (NICE) has provisionally approved sofosbuvir (brand name Sovaldi) for the treatment of hepatitis C, a decision that has surprised some commentators given its high price. The drug’s price in the United States of $84k for a 12 week course would be £54.6k at the current exchange rate of $/£0.65. But Gilead […]

Read More…